Why the study?
Do thienopyridines (ticlopidine and clopidogrel) increase surgical bleeding risk in patients undergoing coronary bypass graft operations?
Do thienopyridines (ticlopidine and clopidogrel) increase surgical bleeding risk in patients undergoing coronary bypass graft operations?
No takes yet. Share an insight, caveat, or question.
This editorial discusses the balance between ischemic benefit and surgical bleeding risk associated with newer antiplatelet agents like clopidogrel.
Bavry et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: